Eplerenone improves pulmonary vascular remodeling and hypertension by inhibition of the mineralocorticoid receptor in endothelial cells

May 10, 2021 3:13 pm Published by

Kowalski J, Deng L, Suennen C, Koca D, Meral D, Bode C, Hein L, Lother A. Eplerenone improves pulmonary vascular remodeling and hypertension by inhibition of the mineralocorticoid receptor in endothelial cells. Hypertension 2021/78:456-465. doi: 10.1161/HYPERTENSIONAHA.120.16196.

Categorised in:

This post was written by sfb1425